Erika Hamilton MD, FASCO
@erikahamilton9.bsky.social
5.1K followers
1.3K following
170 posts
Director of Breast Cancer Research Program at Sarah Cannon Research Institute | Wife | Mom to 2 Girls | Tweets are My Own #Oncology #BCSM, #Cancer.
Posts
Media
Videos
Starter Packs
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO
OncLive
@onclive.bsky.social
· Apr 16
Molecular Profiling, Endocrine Sensitivity Are Key to Managing Later-Line HR+/HER2-Negative Breast Cancer
Erika P. Hamilton, MD, discusses the current role of CDK4/6 inhibitors and evolving targeted therapies in advanced HR-positive, HER2-negative breast cancer.
www.onclive.com
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO
Reposted by Erika Hamilton MD, FASCO